RNTX logo
RNTX NASDAQ US

Rein Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2017
$1.21
▲ +$0.00 (+0.00%)
Vol 155K
1
Quality Score
fail
Mkt Cap
$30.5M
ROE
-118.7%
D/E
0.00
Beta
1.44
52W
$1–$4

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating

Price Chart

Earnings

Beat rate: 20.0%
Next Report May 13, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026
Dec 2025 $-0.22 $-1.09 $-0.87
Sep 2025 $-0.24 $-0.21 +$0.03
Jun 2025 $-0.22 $-0.28 $-0.06

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -95.6% -95.6% -95.6% -95.6% -118.7% -118.7%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 0.86 0.86 0.86 0.86 0.90 0.90

Key Ratios

ROA (TTM)
-102.0%
EPS (TTM)
$-2.63
52W High
$3.50
52W Low
$1.04
$1.04 52-Week Range $3.50

How does RNTX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

RNTX AAPG ABEO ABOS ABP

RNTX valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

RNTX profitability vs Biotechnology peers

ROE
-118.7%
76% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-102.0%
118% below peers (-46.7%)
vs Peers
vs Industry
Weak

RNTX financial health vs Biotechnology peers

D/E ratio
0.0
0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.9
80% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.4
49% above peers (1.0)
vs Peers
vs Industry
More volatile

RNTX fundamentals radar

RNTX Peer median Industry

RNTX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

RNTX vs peers: key metrics

Latest News

No related news yet